| NCT06310291 | VTP-1000 in Adults With Celiac Disease | RECRUITING | EARLY_PHASE1 | 2024-08-01 | 2026-06 | 2026-06 |
| NCT05617040 | Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer | TERMINATED | PHASE1, PHASE2 | 2023-01-30 | 2025-02-05 | 2025-02-05 |
| NCT05343481 | Efficacy of VTP-300 in Chronic Hepatitis B Infection | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-09-21 | 2026-10 | 2026-02 |
| NCT04607850 | Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions | COMPLETED | PHASE1, PHASE2 | 2021-03-16 | 2024-01-16 | 2024-01-16 |
| NCT04778904 | First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV | COMPLETED | PHASE1, PHASE2 | 2020-12-22 | 2023-02-24 | 2023-02-24 |
| NCT03883113 | Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model | COMPLETED | PHASE2 | 2019-06-03 | 2020-04-17 | 2019-12-16 |
| NCT03880474 | Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults | TERMINATED | PHASE2 | 2019-03-18 | 2020-01-21 | 2019-10-15 |
| NCT04297917 | First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection | COMPLETED | PHASE1 | 2019-02-10 | 2022-06-26 | 2022-05-23 |
| NCT03300362 | Improved Novel VaccIne CombinaTion InflUenza Study | TERMINATED | PHASE2 | 2017-10-13 | 2018-10-31 | 2018-10-31 |
| NCT03277456 | A Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1 | COMPLETED | EARLY_PHASE1 | 2017-09-18 | 2017-11-02 | 2017-11-02 |